Literature DB >> 19891586

The liver in 30-year-old individuals with alpha(1)-antitrypsin deficiency.

E Bernspång1, J Carlson, E Piitulainen.   

Abstract

OBJECTIVE. Severe (PiZZ) alpha(1)-antitrypsin (AAT) deficiency is a risk factor for liver disease, i.e. juvenile cirrhosis in infancy, and cirrhosis and hepatoma in adulthood. Little is known about the risk of liver disease in individuals with moderate (PiSZ) AAT deficiency. To investigate the natural course of AAT deficiency, a cohort of PiZZ and PiSZ individuals identified by the Swedish National neonatal screening programme in 1972-74 is followed regularly. The aim of this study was to compare liver function in this cohort with healthy control subjects aged 30 years. MATERIAL AND METHODS. Blood samples were obtained from 89 PiZZ, 40 PiSZ, and 84 control subjects (PiMM), and plasma levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl (GT) transpeptidase were analysed. RESULTS. The mean values of all liver enzymes were within the normal range in all Pi subgroups. However, the mean AST was higher in the PiZZ and PiSZ subgroups than in the PiMM subgroup (p < 0.001), and the mean ALT was higher in the PiZZ individuals than in the controls (p < 0.05), while GT did not differ significantly among the Pi subgroups. The PiZZ women taking oral contraceptives had higher mean AST and ALT (p < 0.01) and GT (p < 0.05) than the control women taking oral contraceptives. CONCLUSIONS. At the age of 30 years, PiZZ and PiSZ individuals have normal plasma levels of the transaminases AST and ALT, although they are significantly higher than those in healthy control subjects. Use of oral contraceptives seems to influence liver enzymes in PiZZ women.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19891586     DOI: 10.3109/00365520903296669

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

1.  Two New Considerations for Improving the Diagnosis of α1-Antitrypsin Deficiency-Associated Liver Disease.

Authors:  David H Perlmutter; Kapil Chopra; Andrew Chu
Journal:  Dig Dis Sci       Date:  2015-06       Impact factor: 3.199

Review 2.  Diagnosis and management of patients with α1-antitrypsin (A1AT) deficiency.

Authors:  David R Nelson; Jeffrey Teckman; Adrian M Di Bisceglie; David A Brenner
Journal:  Clin Gastroenterol Hepatol       Date:  2011-12-23       Impact factor: 11.382

3.  Non-invasive assessment for alpha-1 antitrypsin deficiency-associated liver disease: new insights on steatosis and fibrosis in Pi*ZZ carriers.

Authors:  Siyer Roohani; Frank Tacke
Journal:  Transl Gastroenterol Hepatol       Date:  2019-12-12

4.  Liver test results do not identify liver disease in adults with α(1)-antitrypsin deficiency.

Authors:  Virginia C Clark; Renumathy Dhanasekaran; Mark Brantly; Farshid Rouhani; Pamela Schreck; David R Nelson
Journal:  Clin Gastroenterol Hepatol       Date:  2012-07-24       Impact factor: 11.382

5.  The prevalence of alpha-1 antitrypsin deficiency in Ireland.

Authors:  Tomás P Carroll; Catherine A O'Connor; Olwen Floyd; Joseph McPartlin; Dermot P Kelleher; Geraldine O'Brien; Borislav D Dimitrov; Valerie B Morris; Clifford C Taggart; Noel G McElvaney
Journal:  Respir Res       Date:  2011-07-13

6.  Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age.

Authors:  Behrouz Mostafavi; Sandra Diaz; Hanan A Tanash; Eeva Piitulainen
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

7.  Genome-wide association meta-analysis yields 20 loci associated with gallstone disease.

Authors:  Egil Ferkingstad; Asmundur Oddsson; Solveig Gretarsdottir; Stefania Benonisdottir; Gudmar Thorleifsson; Aimee M Deaton; Stefan Jonsson; Olafur A Stefansson; Gudmundur L Norddahl; Florian Zink; Gudny A Arnadottir; Bjarni Gunnarsson; Gisli H Halldorsson; Anna Helgadottir; Brynjar O Jensson; Ragnar P Kristjansson; Gardar Sveinbjornsson; David A Sverrisson; Gisli Masson; Isleifur Olafsson; Gudmundur I Eyjolfsson; Olof Sigurdardottir; Hilma Holm; Ingileif Jonsdottir; Sigurdur Olafsson; Thora Steingrimsdottir; Thorunn Rafnar; Einar S Bjornsson; Unnur Thorsteinsdottir; Daniel F Gudbjartsson; Patrick Sulem; Kari Stefansson
Journal:  Nat Commun       Date:  2018-11-30       Impact factor: 14.919

8.  Comparison of non-invasive assessment of liver fibrosis in patients with alpha1-antitrypsin deficiency using magnetic resonance elastography (MRE), acoustic radiation force impulse (ARFI) Quantification, and 2D-shear wave elastography (2D-SWE).

Authors:  Rolf Reiter; Martin Wetzel; Karim Hamesch; Pavel Strnad; Patrick Asbach; Matthias Haas; Britta Siegmund; Christian Trautwein; Bernd Hamm; Dieter Klatt; Jürgen Braun; Ingolf Sack; Heiko Tzschätzsch
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.